Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT06010303
Eligibility Criteria:
Inclusion Criteria:
* Able to provide written informed consent and can agree to comply with the study requirements.
* Participants with metastatic ESCC or unresectable, locally advanced ESCC.
* Histologically confirmed diagnosis of ESCC.
* Can provide a tumor sample.
* At least 1 measurable lesion as defined by RECIST v1.1.
* Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 1.
Exclusion Criteria:
* Prior treatment for advanced or metastatic ESCC within the past 6 months
* Locally advanced ESCC that is either resectable or potentially curable with definitive chemoradiation treatment per local investigator
* Palliative radiation treatment for ESCC within the past 4 weeks
* Participants with an esophageal/bronchial or esophageal/aorta fistula
* Prior treatment with programmed cell death protein-1 (PD-1) or other immune-oncological drugs
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06010303
Study Brief:
Protocol Section:
NCT06010303